Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.cision.com
Cision News
Get the latest updates from Cision News directly as they happen.
Follow now 30 followers
Latest posts
Last updated 4 months ago
AbbVie’s SKYRIZI[®] (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis
4 months ago
PRESS RELEASE – For UK consumer health, medical and trade media only...
AbbVie’s SKYRIZI[®] (risankizumab) Is Recommended by NICE as an Option for Use in Adults with Moderately to Severely Active Ulcerative Colitis
9 months ago
For UK consumer, medical and trade media only · In final guidance...
AbbVie Announces New UK Vice President and General Manager
10 months ago
For UK trade and national media · Steve Hopkinson has been appointed...
SMC Approves First Subcutaneous Bispecific Treatment Option Tepkinly[® ]▼(epcoritamab) for Adults with an Aggressive Form of Blood Cancer After Two or More Lines of Systemic Therapy
11 months ago
· For the first time, adults in Scotland with diffuse large B-cell...
AbbVie’s AQUIPTA[®]▼(atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults
about 1 year ago
PRESS RELEASE - For UK consumer, medical and trade media only ·...
AbbVie’s Produodopa® (foslevodopa-foscarbidopa) Accepted by Scottish Medicines Consortium as Treatment Option for Advanced Levodopa-Responsive Parkinson’s Disease
about 1 year ago
For Medical and Trade media · Foslevodopa-foscarbidopa will soon be available for...
MHRA Approves RINVOQ[®]▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn's Disease
over 2 years ago
PRESS RELEASE - For UK Consumer Health, Medical and Trade media only...
Scottish Medicines Consortium (SMC) Extends Advice Accepting RINVOQ®▼(upadacitinib) For Treatment of Adults with Moderate Rheumatoid Arthritis
over 2 years ago
· Upadacitinib, a once daily pill, which was previously accepted by the...
NICE recommends RINVOQ[®]▼ (upadacitinib) As Treatment Option For Moderately to Severely Active Ulcerative Colitis in Adults
over 2 years ago
PRESS RELEASE - For UK Medical and trade media only · The...
Scottish Medicines Consortium Accepts RINVOQ[®]▼ (upadacitinib) For Treatment of Moderately to Severely Active Ulcerative Colitis in Adults
over 2 years ago
PRESS RELEASE - For Scottish Consumer Health and UK Medical and trade...
NICE Recommends RINVOQ[®]▼(upadacitinib) As A Treatment Option For Active Ankylosing Spondylitis (AS) In Adults
over 2 years ago
· Publication of a positive Final Appraisal Document (FAD) means RINVOQ[®]▼(upadacitinib) will...
NICE Recommendation Expands Patient Eligibility for AbbVie’s Ozurdex[® ](dexamethasone 0.7mg intravitreal implant) in Diabetic Macular Oedema (DMO)
almost 3 years ago
PRESS RELEASE - For UK medical and trade media only · NICE...